Protocol Ledger

NCT03643276 · Phase III · RECRUITING

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

Interventional Phase III clinical trial protocol NCT03643276 sponsored by Martin Schrappe in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2018-07-15 Enrollment: 5,000 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT03643276
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)5,000 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03643276
Protocol FieldVerified Registry Value
NCT IdentifierNCT03643276
Consolidated Lead SponsorMartin Schrappe
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment5,000 participants (ESTIMATED)
Registered Start Date2018-07-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT03643276
Hospital Research SiteLocationSite Profile
The Children's Hospital at WestmeadWestmead, AustraliaOpen Hospital Dossier ->
Universitaetsklinikum EssenEssen, GermanyOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI